The Invisible Threat: Why Micronanoplastics are a Systemic Immune Problem Across All Organ Systems
Published in Earth & Environment and Immunology
The Spark: Why This Review Now?
Over the last few years, research has confirmed that we ingest and inhale thousands of micronanoplastic (MNP) particles daily. Yet, the scientific community often operates in silos—studies on pulmonary effects are disconnected from those on reproductive failure or neurotoxicity.
This fragmentation led us to a crucial question: Is there a common mechanism linking these disparate adverse outcomes? We realized the scientific landscape required a comprehensive synthesis that connected these isolated "islands" of data, defining MNPs as a systemic, immunity-driven health problem.
The Challenge: Mapping the Immune Highway
The task was colossal. We had to synthesize evidence from human, animal, and in vitro models, covering eight major body systems (nervous, endocrine, respiratory, digestive, and others).
The greatest challenge was reconciling the vast differences in MNP data—particles varied in shape, size, material, and concentration across studies. We needed to identify a universal language of toxicity that could explain why such diverse particles lead to such consistently alarming pathologies.
Our Key Finding: Inflammation is the Common Thread
Our analysis revealed that MNPs are not passive, inert particles; they are active disruptors of cellular processes. The core mechanism of their harm is a cascading immune dysfunction, primarily manifesting through two pathways:
-
Oxidative Stress: MNPs induce excessive production of free radicals, damaging cells across all organs.
-
Immune Dysregulation: The particles trigger persistent, low-grade inflammation that can contribute to neuroinflammation, endocrine disruption, and other chronic illnesses.
In essence, we found that the immune system acts as the highway through which MNPs exert their systemic effects across the entire body.
The Research Agenda: What Happens Next?
Our review is not an endpoint; it is a roadmap. It’s a clear call to action for the scientific community. To effectively combat this global threat, standardization is essential. We urge researchers to:
-
Standardize Protocols: Adopt unified testing protocols and MNP characterization metrics to make results truly comparable globally.
-
Focus on Nanoplastics: Increase research on the smallest fraction—nanoplastics—as their capacity to cross biological barriers (like the blood-brain and placental barriers) presents the most significant threat.
-
Transition to Clinical Relevance: Develop clinical intervention and prevention strategies to protect human health from this pervasive environmental danger.
Follow the Topic
-
Discover Medicine
This is a fully open access, peer-reviewed journal that supports multidisciplinary research and policy developments across the fields of medical and clinical science.
Related Collections
With Collections, you can get published faster and increase your visibility.
Gut Microbiome and Human Well Being
The human gut microbiome plays a critical role in maintaining health and modulating disease processes. Its composition evolves across the lifespan under the influence of diet, lifestyle, aging, and environmental exposures. Disruption of gut microbial balance—known as dysbiosis—has been implicated in the pathogenesis of various chronic conditions, including autoimmune, metabolic, neurological, and inflammatory diseases.
This Collection welcomes submissions that explore the mechanistic, clinical, and translational aspects of gut microbiota in human health, with particular interest in:
The gut–brain, gut–heart, gut–cancer, and gut–joint axes
Gut dysbiosis and its immunological and metabolic consequences
Microbial metabolites and host-microbiome interactions
Microbiome-based diagnostics, therapeutic interventions, and biomarkers
We invite contributions including but not limited to:
Original research articles based on clinical, in vivo or in vitro studies
Reviews summarizing recent advances or proposing new frameworks
Perspective or opinion pieces that highlight emerging concepts or challenges
This Collection aims to enhance our understanding of the gut microbiome's contribution to health and disease and to inspire microbiome-based strategies for improving human well-being.
Keywords: Gut microbiome; Gut-organ-axis; chronic diseases; 16S rRNA; metagenomics
Publishing Model: Open Access
Deadline: Dec 31, 2026
Innovative Laboratory and Epidemiological Strategies to Reduce Mortality of Non-Communicable Chronic Diseases
Non-communicable chronic diseases (NCDs) and related conditions remain the leading causes of morbidity and mortality worldwide. These include two major categories: non-communicable chronic diseases—such as cardiovascular diseases, chronic respiratory diseases, and diabetes mellitus—and external causes, including accidents and violence. In parallel, advances in laboratory sciences and the growing field of precision medicine have opened new possibilities for early diagnosis, risk stratification, and personalized management. These approaches aim not only to identify individuals at greater risk of developing NCDs, but also to monitor disease progression and the emergence of complications or comorbidities. In this context, innovative laboratory methods and novel biomarkers are urgently needed to enhance disease detection and surveillance strategies. We therefore invite researchers to submit original articles, reviews, and case studies addressing the role of precision medicine in improving the surveillance and clinical management of chronic non-communicable diseases and their progression.
Keywords: Non-communicable chronic diseases; disease aggravation; biomarkers; laboratory methods; epidemiological aspects; individual risk classification; precision medicine; health promotion; surveillance; innovative laboratory approaches.
Publishing Model: Open Access
Deadline: Aug 31, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in